CD
Christopher C Dewey
Director

Christopher C Dewey insider trades: Myos Rens Technology (MYOS) stock buys and sales

Director, Myos Rens Technology Last trade Mar 5, 2020 39 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
17
Open-market trades
since 2007
5
Companies
last trade 2020

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Christopher reports to the SEC

Open-market buys and sales

17 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 5, 2020MYOS↑ Buy$100K
Nov 14, 2012MAKO↑ Buy$329K
Dec 1, 2010MAKO↓ Sell$116K
Dec 2, 2009MAKO↓ Sell$92K
Nov 25, 2009MAKO↓ Sell$79K
Oct 31, 2008MAKO↑ Buy$200K
Oct 14, 2008NHLD.OB↑ Buy$5K
Aug 18, 2008NHLD.OB↑ Buy$10K
Aug 7, 2008MAKO↑ Buy$710
Aug 4, 2008MAKO↑ Buy$100K
Apr 2, 2008MAKO↑ Buy$10K
Dec 26, 2007NHLD.OB↑ Buy$7K
Dec 20, 2007NHLD.OB↑ Buy$14K
Dec 17, 2007NHLD.OB↑ Buy$8K
Apr 2, 2007NHLD.OB↑ Buy$32K
Mar 30, 2007NHLD.OB↑ Buy$197K
Mar 26, 2007NHLD.OB↑ Buy$19K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Christopher C Dewey's insider trades

Christopher C Dewey is a director at Myos Rens Technology (MYOS). Since Mar 26, 2007, Christopher has reported 14 open-market purchases worth $1.0M and 3 sales worth $287K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include other transactions (9 filings), grants and awards (8 filings), shares returned to the company (4 filings), conversions (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MYOS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.